Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg
To gather information on the safety of monotherapy of Casodex® tablets 80 mg, targeting prostate cancer patients who have no history of having received treatment by either endocrine therapy (including surgical castration).
Prostate Cancer
Adverse event incidence, Time since starting Casodex monotherapy, monthly
improvement of prostate cancer using Tumor marker PSA, Time since starting Casodex monotherapy, monthly|Maintenance of sexual function, At 3 months since starting Casodex monotherapy,
To gather information on the safety of monotherapy of Casodex® tablets 80 mg, targeting prostate cancer patients who have no history of having received treatment by either endocrine therapy (including surgical castration).